PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0220
    Neoadjuvant immune checkpoint blockade (ICB) is a new treatment approach that has gained traction in esophageal cancer patients. Neoadjuvant cancer therapy refers to the administration of cancer treatment before performing a curative surgery for patients who have not yet received any treatment for their condition. Neoadjuvant chemotherapy and radiotherapy aim to shrink tumors for better surgical outcomes. Recent evidence suggests neoadjuvant immunotherapy can enhance intratumoral and systemic anti-tumor immunity by expanding and transcriptionally modifying tumor-specific T-cell subclones. It provides a unique opportunity to study mechanisms and discover ICB response and resistance biomarkers, leading to better predictions of long-term clinical outcomes and the development of more effective ICB combination therapies. Since there is a scarcity of high-level evidence to guide, medical and ethical risks persist. The current consensus has been revised based on new and practice-changing data. The current updates are based on an evidence review and adhere to the guideline development processes. This consensus aims to quickly provide up-to-date recommendations to healthcare practitioners and the public on the most effective cancer care options available.
  • 2024.0220
    Esophagectomy with radical lymphadenectomy is a complex surgery that carries a significant risk of morbidity and mortality for patients with esophageal cancer. The enhanced recovery after surgery (ERAS) protocol aims to improve perioperative care, minimize complications, and accelerate recovery for better outcomes. ERAS is a multimodal approach that can shorten hospital stays, decrease morbidity, and expedite recovery. ERAS components should be viewed as a continuum rather than isolated elements, as they span preoperative, intraoperative, and postoperative periods. In this consensus, we elaborate on the components of an ERAS protocol after esophagectomy, including preoperative nutrition, prehabilitation, counseling, smoking and alcohol cessation, cardiopulmonary evaluation, surgical technique, anesthetic management, intra- and postoperative fluid management and pain relief, mobilization and physiotherapy, enteral and oral feeding, removal of drains, and several other components.
  • 2024.0219
    This consensus is formulated in order to further improve the level of diagnosis and treatment of adult central neuropsychiatric lupus in China, and promote the standardization of clinical practice in rheumatology and immunology. The development of high-quality expert consensus on clinical practice can not only improve the overall level of disease diagnosis and treatment, reduce the burden of patients and families, but also help to reduce social medical costs and promote the rational use of medical resources.
Registration process and operational mode of a CPG registry